Boothbay Fund Management, LLC Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $264,932 - $432,922	21,400 New	21,400 $396,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $426,627 - $689,931	-62,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $70,070 - $337,883	9,100 Added 17.17%	62,100 $607,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $1.4 Million - $1.97 Million	53,000 New	53,000 $1.8 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.